Patent Issued for 17a-monoesters and 17a,21-diesters of cortexolone for use in the treatment of tumors (USPTO 11986484).
In: Cancer Weekly, 2024-06-11, S. 1955-1955
serialPeriodical
Zugriff:
A patent has been issued for 17a-monoesters and 17a,21-diesters of cortexolone for use in the treatment of tumors. The patent was filed by Mara Gerloni and is assigned to Cosmo Technologies Limited. The patent discusses the importance of treating epithelial tumors, particularly pancreatic carcinoma, which is one of the most deadly forms of cancer. The invention provides certain cortexolone derivatives for use as antitumor active ingredients in the treatment of precancerous lesions, dysplasias, metaplasias, and malignant neoplasias. The patent also includes methods of treating specific tumor diseases, such as prostate carcinoma and lung carcinoma, with the compounds. [Extracted from the article]
Copyright of Cancer Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Patent Issued for 17a-monoesters and 17a,21-diesters of cortexolone for use in the treatment of tumors (USPTO 11986484).
|
---|---|
Zeitschrift: | Cancer Weekly, 2024-06-11, S. 1955-1955 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1071-7218 (print) |
Sonstiges: |
|